Press Release: Civis Analytics : New Research Suggests How to Message the Eventual COVID-19 Vaccine in the US
CHICAGO, Sept. 9, 2020 /PRNewswire/ -- Data science firm Civis Analytics today released research on the efficacy of various messaging themes in encouraging adoption of the eventual COVID-19 vaccine. Leveraging a randomized controlled trial (the scientific gold standard used in clinical...
Read full article »
Civis is an Illinois-based cloud platform that offers solutions such as proprietary data, advisory and identity resolution for healthcare, media and educational organizations.
Read more